|
Showing 1 - 4 of
4 matches in All Departments
Many voluntary health organizations fund translational research. An
increasing number of these organizations are looking at venture
philanthropy as a critical way to advance their missions of helping
patients and working to cure disease.
A wide range of participants gathered on October 3, 2008 at the
Beckman Center of the National Academies of Science for a workshop
titled "Venture Philanthropy Strategies Used by Patient
Organizations to Support Translational Research." Participants with
experience in venture philanthropy shared their experiences and
lessons learned in order to improve efficiency and effectiveness in
translational research.
Biomarkers, or biological markers, are quantitative measurements
that offer researchers and clinicians valuable insight into
diagnosis, treatment and prognosis for many disorders and diseases.
A major goal in neuroscience medical research is establishing
biomarkers for disorders of the nervous system. Given the promising
potential and necessity for neuroscience biomarkers, the Institute
of Medicine Forum on Neuroscience and Nervous System Disorders
convened a public workshop and released the workshop summary
entitled Neuroscience Biomarkers and Biosignatures: Converging
Technologies, Emerging Partnerships. The workshop brought together
experts from multiple areas to discuss the most promising and
practical arenas in neuroscience in which biomarkers will have the
greatest impact. The main objective of the workshop was to identify
and discuss biomarker targets that are not currently being
aggressively pursued but that could have the greatest near-term
impact on the rate at which new treatments are brought forward for
psychiatric and neurological disorders. Table of Contents Front
Matter Summary Introduction 1 Biomarker and Biosignature Principles
2 Potential Tools for Biomarker and Biosignature Development 3
Psychiatric and Drug Addiction Disorders 4 Neurological and Eye
Diseases A References B Public Workshop on Neuroscience Biomarkers
and Biosignatures: Converging Technologies, Emerging Partnerships C
Workshop Attendees D Biographical Sketches of Invited Speakers,
Committee Members, and Staff
|
You may like...
LSD
Labrinth, Sia, …
CD
R213
R112
Discovery Miles 1 120
|